The Food and Drug Administration is set to hold crucial meetings over the next two days to decide whether to issue booster shots of Johnson & Johnson and Moderna COVID vaccines. Follow Newsweek's liveblog for all the latest.
A Food and Drug Administration advisory panel will hold crunch talks over Thursday and Friday on whether to support booster doses of both the Johnson & Johnson and Moderna COVID-19 vaccines.decision is seen as crucial for both companies and Biden administration's vaccine rollout program
, but scientific data, as ever in politics, is only one part of the story and can be read in a number of ways.
President Biden's chief medical advisor said yesterday afternoon that airline pilots should be far more concerned about the potential health consequences of contracting COVID-19 than any risk of possible side effects from vaccines. We have examples of people - they may not necessarily be pilots, maybe there are some - who actually have gotten COVID and have had an unexplained but real impact on their ability to function normally.
Common side effects from all vaccines include a sore arm, a low-grade fever, and other mild flu-like symptoms lasting only a few days.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Johnson & Johnson Covid-19 Booster Shot Bolsters Immune Defense, FDA Staff SayA booster shot of Johnson & Johnson’s Covid-19 vaccine showed signs of significantly bolstering the immune defenses of study subjects, said FDA regulators, who cautioned that their data was limited
続きを読む »
Moderna has no plans to share its COVID-19 vaccine recipe, aims to increase production insteadModerna won't share the recipe for its COVID-19 vaccine because execs have concluded that scaling up the company’s own production is the best way to increase the global supply, the company’s chairman said.
続きを読む »
U.S. FDA staff says Moderna did not meet all criteria for COVID-19 boostersScientists at the U.S. Food and Drug Administration said on Tuesday that Moderna Inc had not met all of the agency's criteria to support use of booster doses of its COVID-19 vaccine, possibly because the efficacy of the shot's first two doses has remained strong.
続きを読む »
J&J Covid-19 Vaccine Recipients May Benefit More From Pfizer Or Moderna Boosters, Study FindsJ&J recipients who were administered Moderna or Pfizer boosters showed significantly higher antibody counts compared to those who received a booster of the same vaccine.
続きを読む »
Moderna Won’t Share Its COVID Vaccine FormulaModerna's chairman says the company will not share the formula for its COVID-19 vaccine with other companies despite calls from international organizations for the company to do so.
続きを読む »
FDA to take up Moderna, J&J Covid-19 booster questions this weekVaccine advisers to the FDA meet Thursday and Friday of this week to tackle the next round of questions about booster vaccines for Covid-19 — and they might be seeing the first trickle of data on mix-and-match boosters.
続きを読む »